Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Indication
A medical condition which makes a particular drug treatment or procedure advisable in line with the Product License. Drug approvals for specific indications are controlled in most countries and jurisdictions by a licensing body, including the Food and Drug Administration (FDA) in the US and the European Medical Association (EMA) in the EU.
See also:
Food And Drug Administration (FDA)
License (product)
Related terms
Placebo, Compassionate use, United States adopted name (USAN), Bias, New Drug Application (NDA), Protocol, Defined daily dose (DDD), Product pipeline, Experimental drug, Epidemiology, Orphan drugs, Cost-minimisation analysis (CMA), Disease awareness marketing, Effectiveness, Pharmaceutical Researchers and Manufacturers of America (PhRMA),
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- My body. My choice. Are we all talking about the same thing?
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Sanofi halts recruitment for trials assessing MS treatment
- Merck and Cerevance to research novel targets in Alzheimer’s disease
- Michael J Fox Foundation awards Koneksa second research grant
- FDA approves Bot Image’s AI software for the detection and diagnosis of prostate cancer
- GSK/Merck KGgA cancer drug fails in third trial
- GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention
- Avastin wins EU approval for advanced renal cancer
- Chiesi Group's Trimbow wins European licence
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Merck and Cerevance to research novel targets in Alzheimer’s disease
